An Open, Multicenter Study of the Safety and Tolerability of VAQTA(TM) and ProQuad(TM) in Healthy Children 12 to 23 Months of Age
Phase of Trial: Phase IV
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Hepatitis A vaccine; MMR-varicella zoster virus vaccine
- Indications Chickenpox; Hepatitis A; Measles; Mumps; Rubella
- Focus Adverse reactions
- Sponsors Merck & Co
- 18 Nov 2008 Secondary trial identifier 'V251-066' found and added according to ClinicalTrials.gov.
- 18 Nov 2008 Last checked against ClinicalTrials.gov record.
- 18 Nov 2008 Actual patient number identified as 1800 from ClinicalTrials.gov.